Regardless, disruption of the IL-6 axis (including IL-6R and gp130), and in turn, the production of acute phase cytokines, has been implicated in multiple chronic inflammatory conditions, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and psoriasis [176]. This evidence concerns the gene IL6 and rheumatoid arthritis.